Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

101.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

Lancet.
O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.
| Sep 19, 2009
102.

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.

Lancet.
Sabatine MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, Polasek R, Contant CF, McCabe CH, Braunwald E.
| Sep 5, 2009
103.

HPV vaccine for all.

Lancet.
Michels KB, zur Hausen H.
| Jul 25, 2009
104.

Multiple myeloma.

Lancet.
Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC.
| Jul 25, 2009
105.

Bladder cancer.

Lancet.
Kaufman DS, Shipley WU, Feldman AS.
| Jul 18, 2009
106.

Diabetes: finding "a clean well-lighted place".

Lancet.
Jacobson AM.
| May 23, 2009
107.

Gestational diabetes mellitus: an opportunity of a lifetime.

Lancet.
Bentley-Lewis R.
| May 23, 2009
108.

Painless jaundice with serial multi-organ dysfunction.

Lancet.
Khosroshahi A, Stone JR, Pratt DS, Deshpande V, Stone JH.
| Apr 25, 2009
109.

Can the polypill save the world from heart disease?

Lancet.
Cannon CP.
| Apr 18, 2009
110.

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

Lancet.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ.
| Apr 4, 2009
111.

Caregiving: the odyssey of becoming more human.

Lancet.
Kleinman A.
| Jan 24, 2009
112.

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

Lancet.
Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
| Feb 7, 2009
113.

Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis.

Lancet.
Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH.
| Dec 6, 2008
114.

Violence and the role of illness narratives.

Lancet.
Westerhaus M, Panjabi R, Mukherjee J.
| Aug 30, 2008
115.

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.

Lancet.
Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS.
| Oct 18, 2008
116.

Promise of improving metabolic and lifestyle risk in practice.

Lancet.
Mozaffarian D.
| Jun 14, 2008
118.

Liver cirrhosis.

Lancet.
Schuppan D, Afdhal NH.
| Mar 8, 2008
119.

Activated vitamin D sterols in kidney disease.

Lancet.
Thadhani R.
| Feb 16, 2008
120.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Lancet.
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL.
| Feb 2, 2008